Genomic and nuclear organizational changes in chemotherapy-resistant rhabdomyosarcoma cells |
Ann & Robert H. Lurie Children’s Hospital of Chicago / Kyle MacQuarrie, MD/PhD |
'A' Award Grants |
2023 |
Illinois |
Exploiting the Differentiation Potential of Pediatric High-Grade Glioma to Discover Novel Therapeutic Opportunities |
Dana-Farber Cancer Institute / Mariella Filbin, MD/PhD |
'A' Award Grants |
2019 |
Massachusetts |
Genetically Modified, Cord Blood Derived Natural Killer Cell Therapy for High Grade Pediatric Brain Tumors |
Children’s Research Institute / Conrad Russell Cruz, MD, PhD |
'A' Award Grants |
2015 |
District of Columbia |
Targeting Kinase Inhibitor Induced DNA-Damage Response in Ph-Like ALL |
Temple University / Christian Hurtz, PhD |
'A' Award Grants |
2022 |
Pennsylvania |
BET Bromodomain Inhibition as Epigenetic Therapy in Pediatric Leukemia |
Cold Spring Harbor Laboratory / Christopher Vakoc, MD, PhD |
'A' Award Grants |
2012 |
New York |
Investigating the Role of Genetic and Epigenetic Variation in Risk of Childhood Acute Lymphoblastic Leukemia in Down Syndrome |
University of California San Francisco / Adam de Smith, Ph.D. |
'A' Award Grants |
2014 |
California |
Targeting Metabolism in Alveolar Soft Part Sarcomagenesis |
Huntsman Cancer Institute / Kevin Jones, MD |
'A' Award Grants |
2013 |
Utah |
The Interplay Between Histone Mutations and Replication Stress in Shaping Glioma Phenotypes |
Dana-Farber Cancer Institute / Pratiti Bandopadhayay, PhD |
'A' Award Grants |
2021 |
Massachusetts |
Role of Primary Cilium Signaling and Dynamics in Medulloblastoma Initiation and Progression |
University of Texas Southwestern Medical Center / Saikat Mukhopadhyay, MD/PhD |
'A' Award Grants |
2016 |
Texas |
DNA Damage Responses Coordinate Survival and Cell Death Switching In Lymphocytes |
Washington University / Jeffrey Bednarski, MD, PhD |
'A' Award Grants |
2013 |
Missouri |